Enanta Pharmaceuticals Insider Trades
NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 9 · $183.17K
- Shares bought / sold
- 0 / 12.88K
- Net activity
- Net selling $183,167
Enanta Pharmaceuticals insider activity
Over the last 12 months, Enanta Pharmaceuticals insiders reported 36 transactions on SEC Form 4: 0 open-market purchases and 9 sales. Insiders bought $0 and sold $183,167 worth of stock, for net insider selling of $183,167. The largest seller was Luly Jay R., with $67,493 in reported sales.
The most recent filing shows Rottinghaus Scott T. (Chief Medical Officer) reporting a transaction in 1,467 shares at $13.34 on Aug 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ENTA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ENTA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 8, 2026 | Rottinghaus Scott T.Chief Medical Officer | Tax withholding | 1,467 | $19.57K | Form 4 |
| Feb 12, 2026 | Luly Jay R.President and CEO | Tax withholding | 6,155 | $87.71K | Form 4 |
| Feb 12, 2026 | Luly Jay R.President and CEO | Award | 15,200 | — | Form 4 |
| Feb 12, 2026 | Luly Jay R.President and CEO | Award | 4,800 | — | Form 4 |
| Feb 12, 2026 | Kieffer Tara LynnChief Product Strategy Officer | Tax withholding | 3,257 | $46.41K | Form 4 |
| Feb 12, 2026 | Kieffer Tara LynnChief Product Strategy Officer | Award | 4,987 | — | Form 4 |
| Feb 12, 2026 | Kieffer Tara LynnChief Product Strategy Officer | Award | 1,575 | — | Form 4 |
| Feb 12, 2026 | Or Yat SunChief Scientific Officer | Tax withholding | 3,413 | $48.64K | Form 4 |
| Feb 12, 2026 | Or Yat SunChief Scientific Officer | Award | 5,225 | — | Form 4 |
| Feb 12, 2026 | Or Yat SunChief Scientific Officer | Award | 1,650 | — | Form 4 |
| Feb 12, 2026 | Rottinghaus Scott T.Chief Medical Officer | Tax withholding | 3,413 | $48.64K | Form 4 |
| Feb 12, 2026 | Rottinghaus Scott T.Chief Medical Officer | Award | 5,225 | — | Form 4 |
| Feb 12, 2026 | Rottinghaus Scott T.Chief Medical Officer | Award | 1,650 | — | Form 4 |
| Feb 12, 2026 | Luu BrendanChief Business Officer | Tax withholding | 3,257 | $46.41K | Form 4 |
| Feb 12, 2026 | Luu BrendanChief Business Officer | Award | 4,987 | — | Form 4 |
| Feb 12, 2026 | Luu BrendanChief Business Officer | Award | 1,575 | — | Form 4 |
| Feb 12, 2026 | Kowalsky Matthew PaulChief Legal Officer | Tax withholding | 1,902 | $27.10K | Form 4 |
| Feb 12, 2026 | Kowalsky Matthew PaulChief Legal Officer | Award | 4,175 | — | Form 4 |
| Feb 12, 2026 | Kowalsky Matthew PaulChief Legal Officer | Award | 1,318 | — | Form 4 |
| Dec 5, 2025 | Capps Kathleen S.See Remarks | Sale | 323 | $4.60K | Form 4 |
| Dec 5, 2025 | Luly Jay R.President and CEO | Sale | 4,743 | $67.49K | Form 4 |
| Dec 5, 2025 | Or Yat SunChief Scientific Officer | Sale | 2,390 | $34.01K | Form 4 |
| Dec 5, 2025 | Kieffer Tara LynnChief Product Strategy Officer | Sale | 2,106 | $29.97K | Form 4 |
| Dec 5, 2025 | Luu BrendanChief Business Officer | Sale | 1,394 | $19.84K | Form 4 |
| Dec 5, 2025 | Rottinghaus Scott T.Chief Medical Officer | Sale | 798 | $11.36K | Form 4 |
| Dec 5, 2025 | Trout Harry R. IIISee Remarks | Sale | 542 | $7.71K | Form 4 |
| Dec 2, 2025 | Capps Kathleen S.See Remarks | Sale | 207 | $2.89K | Form 4 |
| Dec 2, 2025 | Trout Harry R. IIISee Remarks | Sale | 380 | $5.30K | Form 4 |
| Dec 1, 2025 | Luly Jay R.President and CEO | Tax withholding | 1,885 | $26.62K | Form 4 |
| Dec 1, 2025 | Or Yat SunChief Scientific Officer | Tax withholding | 753 | $10.63K | Form 4 |
| Dec 1, 2025 | Kieffer Tara LynnChief Product Strategy Officer | Tax withholding | 753 | $10.63K | Form 4 |
| Dec 1, 2025 | Luu BrendanChief Business Officer | Tax withholding | 498 | $7.03K | Form 4 |
| Dec 1, 2025 | Capps Kathleen S.See Remarks | Tax withholding | 85 | $1.20K | Form 4 |
| Dec 1, 2025 | Trout Harry R. IIISee Remarks | Tax withholding | 105 | $1.48K | Form 4 |
| Nov 25, 2025 | Trout Harry R. IIISee Remarks | Award | 6,463 | — | Form 4 |
| Nov 25, 2025 | Capps Kathleen S.See Remarks | Award | 3,163 | — | Form 4 |
| Aug 8, 2025 | Rottinghaus Scott T.Chief Medical Officer | Tax withholding | 2,217 | $15.50K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4